Inogen Inc INGN

Latest FY: 2025 Healthcare Medical Devices
Market Price $5.77
Market Cap $157.84M
P/E Ratio N/A
Quick Peer Compare (Healthcare):
Revenue (FY 2025) ↑5.9% YoY
$295.30M
3-Yr CAGR: -2.7%
Net Income ↑36.6% YoY
-$22.75M
Net Margin: -7.7%
Free Cash Flow ↓-637.9% YoY
-$13.74M
FCF Yield: -8.70%
EPS (Diluted) ↑43.4% YoY
$-0.86
Basic: $-0.86
Return on Equity Efficiency
-11.8%
ROA: -180.5%

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (INGN)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Op. Cash Flow Free Cash Flow FCF YoY
FY 2016 $168.2M $97.3M $20.5M $0.97 $31.0M $29.3M
FY 2017 $225.5M +34.1% $121.2M $21.0M +2.4% $0.96 -1.0% $60.5M $57.6M +96.4%
FY 2018 $336.0M +49.0% $178.6M $51.8M +146.9% $2.30 +139.6% $60.0M $51.9M -9.8%
FY 2019 $340.5M +1.3% $171.9M $20.9M -59.6% $0.94 -59.1% $40.6M $37.5M -27.9%
FY 2020 $280.2M -17.7% $138.2M $-5.8M -127.8% $-0.27 -128.7% $37.0M $32.6M -12.9%
FY 2021 $311.7M +11.3% $176.5M $-6.3M -8.6% $-0.28 -3.7% $23.6M $18.2M -44.4%
FY 2022 $320.5M +2.8% $153.5M $-83.8M -1,222.8% $-3.67 -1,210.7% $-37.5M $-40.9M -325.2%
FY 2023 $251.6M -21.5% $126.7M $-102.4M -22.3% $-4.42 -20.4% $-3.2M $-8.5M +79.3%
FY 2024 $278.8M +10.8% $154.7M $-35.9M +65.0% $-1.52 +65.6% $5.9M $2.6M +130.2%
FY 2025 $295.3M +5.9% $154.3M $-22.7M +36.6% $-0.86 +43.4% $-11.2M $-13.7M -637.9%
$

Valuation

Market Price $5.77
Market Cap $157.84M
Enterprise Value N/A
P/E Ratio N/A
P/B Ratio 0.81
FCF Yield -8.70%
Dividend Yield N/A
Shares Outstanding 27,074,500
%

Profitability & Margins

Gross Margin 52.24%
Operating Margin -10.23%
Net Margin -7.70%
Return on Equity (ROE) -11.83%
Return on Assets (ROA) -180.52%
Asset Turnover 23.43x
Revenue 3-Yr CAGR -2.70%
🛡️

Financial Health & Liquidity

Current Ratio 0.20
Cash Ratio 1.63
Debt / Equity N/A
Debt / Assets N/A
Cash & Equivalents $103.73M
Total Debt N/A
Book Value / Share $7.10
💧

Cash Flow Efficiency

Operating Cash Flow -$11.22M
Capital Expenditures (CapEx) $2.52M
Free Cash Flow -$13.74M
OCF / Revenue -3.80%
FCF / Revenue -4.65%
FCF 3-Yr CAGR N/A
🏷️

Per Share Metrics

EPS (Diluted) $-0.86
EPS (Basic) $-0.86
Dividends / Share N/A
Book Value / Share $7.10
EPS YoY Growth 43.42%
🏛️

Balance Sheet (FY 2025)

Total Assets $12.60M
Total Liabilities $63.53M
Stockholders' Equity $192.23M
Current Assets $12.60M
Current Liabilities $63.53M